Circle Pharma Inc. said its first collaboration with Pfizer Inc. has led to the identification of a series of bioavailable macrocyclic peptides capable of acting as potent and cell-permeable modulators of CXCR7. [...]
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.
Results from its collaborative work with Pfizer to develop a potent and orally bioavailable macrocycle modulator have been published [...]
Circle Pharma Announces Receipt of Additional Seed Investment, and Relocation to New Laboratory Facility
The seed funding round has been extended with an investment from ShangPharma Investment Group [...]
In 2005, two chemists decided to work together to develop libraries of cyclic peptides that could be used to treat a range of infectious diseases, autoimmunity and cancer [...]
Startup Circle Pharma Inc., a UCSF and UC Santa Cruz spinout devising ways to disrupt a wide variety of diseases from inside cells, will work with Pfizer Inc. on two drug programs [...]